Japanese startup Iwaya Giken is launching a space tourism business to take sightseers on balloon rides 25 kilometers into the stratosphere
Iwaya Giken noted that while passengers need not undergo special training to make the trip but ticket prices would not be cheap, initially starting at around 24 million yen ($178,100) per person.
Company President Keisuke Iwaya said they will be able to reduce the price to the 1 million yen to 2 million yen range in the future.
Iwaya Giken may begin offering the service by the end of the year.
The service lets passengers ride on the balloon that would ascend for two hours, and stay in the stratosphere for an hour, letting them enjoy the view.
The cabin of the 41-meter-high balloon, which seats two people, is spherical and has a 1.5-meter diameter.
The balloon measures 41 meters high and has a spherical two-seater cabin, which is 1.5 meters in diameter.
The cabin was designed to be impervious to variations in air pressure and temperature. In the event of an emergency, it may be converted into a parachute and outfitted with life support systems.
Iwaya claimed that it created everything in-house to ensure safety, including its communication devices.
By the end of this year, the company hopes to hire five passengers and a pilot for the initial batch of flights, which it hopes to begin from Hokkaido.
It has conducted more than 300 flight tests, with the highest point reaching about 40 kilometers into the sky.
The firm is partnering with a major travel agency, JTB Corp., to organize the tours.
After analyzing the results of the experiments and test flights, JTB Corp. will determine whether it is ready to start selling package deals.


NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead
Heritage, desire and diplomacy: why China still values scotch whisky
The ghost of Robodebt – Federal Court rules billions of dollars in welfare debts must be recalculated
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Why financial hardship is more likely if you’re disabled or sick
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Disaster or digital spectacle? The dangers of using floods to create social media content
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Glastonbury is as popular than ever, but complaints about the lineup reveal its generational challenge
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
S&P 500 Hits Record High as Soft Inflation Data Eases Fed Rate Hike Fears
China Automakers Accelerate Global Expansion as Domestic Car Sales Slump 



